UBS Group »

Etf Ser Solutions loncar cancer shares owned by UBS Group

Quarter-by-quarter ownership of Etf Ser Solutions loncar cancer (CNCR) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Etf Ser Solutions loncar cancer

Tip: Access up to 7 years of quarterly data

All positions including Etf Ser Solutions loncar cancer held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Etf Ser Solutions loncar cancer by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $25k 1.9k 13.47
2023-09-30 $21k 1.9k 10.96
2023-06-30 $36k 2.8k 12.92
2023-03-31 $18k 1.5k 11.99
2022-12-31 $38k 2.7k 13.73
2022-09-30 $37k 2.5k 14.56
2022-06-30 $22k 1.5k 15.06
2021-12-31 $30k 1.2k 24.02
2021-09-30 $48k 1.6k 30.50
2020-12-31 $26k 806 32.26
2020-09-30 $11k 391 28.13
2020-06-30 $58k 2.2k 27.00
2019-12-31 $3.0k 139 21.58
2019-03-31 $49k 2.3k 20.86
2018-12-31 $42k 2.2k 18.99
2018-09-30 $56k 2.3k 24.81
2018-06-30 $64k 2.7k 23.98
2018-03-31 $10k 350 28.57
2016-12-31 $24k 1.1k 21.03
2016-03-31 $17k 769 22.11
2015-12-31 $25k 878 28.47